Active, Not Recruiting
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
NCT01522976
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +24 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States